Ming Xie

1.2k citations
53 papers · 953 indexed · h-index 19
Topics
Cancer-related molecular mechanisms research (8 papers)MicroRNA in disease regulation (6 papers)Cancer Cells and Metastasis (5 papers)
Journals
SHILAP Revista de lepidopterologíaPLoS ONEJournal of Ethnopharmacology

In The Last Decade

Ming Xie

52 papers receiving 943 citations

Peers

Ming Xie
Comparison fields: 5 of 98
  • Molecular Biology 477
  • Cancer Research 287
  • Oncology 141
  • Immunology 122
  • Epidemiology 104
Replace Georgios Tzimagiorgis with:
Georgios Tzimagiorgis Greece
Sellama Nadifi Morocco
Fei Pei China
Walter Stünkel Singapore
Gu‐Jiun Lin Taiwan
Mark Dodson United States
Emanuela Marras Italy
El‐Bdaoui Haddad United Kingdom
Ken Iseki Japan
Ming Xie relative to Georgios Tzimagiorgis Greece Georgios Tzimagiorgis's profile →
Citations per field
00.5×2.7×
Georgios Tzimagiorgis · 1×
Citations per year

Countries citing papers authored by Ming Xie

Since Specialization
Citations

This map shows the geographic impact of Ming Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Xie more than expected).

Fields of papers citing papers by Ming Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Xie. The network helps show where Ming Xie may publish in the future.

Co-authorship network of co-authors of Ming Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Xie. A scholar is included among the top collaborators of Ming Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Xie. Ming Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 8
4 12
5 25
6 14
7 22
8 27
9 10
10
HOXA11-AS: a novel regulator in human cancer proliferation and metastasis
2
11 59
12 17
13 7
14 36
15 25
16 39
17 58
18 18
19 77
20 13

About Ming Xie

Ming Xie is a scholar working on Cancer Research, Internal Medicine and Otorhinolaryngology, having authored 53 papers that have together received 953 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (6 papers) and Cancer Cells and Metastasis (5 papers). The work is most often cited by research in Cancer Research (287 citations), Biochemistry (82 citations) and Biological Psychiatry (18 citations). Ming Xie has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Liang Zhou, Ping Zhang, Ran Liu, Xiao‐Qing Tang, Judy A. Spitzer, Tingting Wu, Xinquan Jiang, Hui Huang, Xiaojie Wang and Jing Li. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Ethnopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026